Our company is delighted to announce today, February 1, 2020, that Pooja Goel, Managing Director and Healthcare Practice Lead at Virgo Investment Group, LLC, is joining Alveo’s Scientific Advisory Board. Having held key operational roles responsible for new market and business opportunities as well as process and clinical improvements, Goel brings a deep bench of knowledge to Alveo.

“Alveo’s advanced diagnostics clear the path to more personalized medicine and better outcomes,” said Ron Chiarello, PhD, CEO of Alveo. “Pooja is the best suited healthcare professional to help align our goal to bring innovative products to connect and empower consumers, healthcare professionals and treatment providers with the ability to Know Sooner, Act Faster™, and make better-informed decisions.”

Pooja Goel is a seasoned healthcare executive with over two decades of experience in the healthcare services delivery sector. She was recently at Landmark Health, the nation’s largest house calls provider as their General Manager of New Business. She also spent over 10+ years at DaVita leading many innovative projects and holding several key operational roles in kidney care, international and population health.

Prior to joining DaVita, Pooja held many operations roles at multiple academic medical centers and began her career at Kaiser Permanente. Pooja holds a bachelor’s degree in microbiology and molecular genetics from the University of California, Los Angeles and a master’s degree in health administration from the Loma Linda University School of Public Health.​

Over the past several months, an impressive group of seasoned leaders has joined our Board.

By Ron Chiarello, PhD, Founder, CEO of Alveo

error: Content Restricted